| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.02 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.38 | 0.02 |